LUMN vs. CLOV
LUMN (Lumen Technologies, Inc.) and CLOV (Clover Health Investments, Corp.) are both stocks. LUMN operates in Telecom Services (Communication Services), while CLOV operates in Healthcare Plans (Healthcare). Over the past 5 years, LUMN returned -5.67%/yr vs -15.01%/yr for CLOV. At a 0.20 correlation, their price movements are largely independent.
Performance
LUMN vs. CLOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LUMN achieves a 27.41% return, which is significantly lower than CLOV's 69.79% return.
LUMN
- 1D
- -0.80%
- 1M
- 7.26%
- YTD
- 27.41%
- 6M
- 12.76%
- 1Y
- 153.20%
- 3Y*
- 73.06%
- 5Y*
- -5.67%
- 10Y*
- -4.16%
CLOV
- 1D
- 9.32%
- 1M
- 52.87%
- YTD
- 69.79%
- 6M
- 50.00%
- 1Y
- 29.55%
- 3Y*
- 57.05%
- 5Y*
- -15.01%
- 10Y*
- —
LUMN vs. CLOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
LUMN Lumen Technologies, Inc. | 27.41% | 46.33% | 190.16% | -64.94% | -55.48% | 38.82% | 1.26% |
CLOV Clover Health Investments, Corp. | 69.79% | -25.40% | 230.85% | 2.43% | -75.01% | -77.82% | 64.41% |
Correlation
The correlation between LUMN and CLOV is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2020 | 0.20 |
Fundamentals
LUMN:
$9.89B
CLOV:
$2.08B
LUMN:
-$1.75
CLOV:
-$0.11
LUMN:
0.81
CLOV:
0.93
LUMN:
0.85
CLOV:
6.14
LUMN:
$12.12B
CLOV:
$2.21B
LUMN:
$1.52B
CLOV:
$939.14M
LUMN:
$1.12B
CLOV:
-$55.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LUMN vs. CLOV — Risk / Return Rank
LUMN
CLOV
LUMN vs. CLOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lumen Technologies, Inc. (LUMN) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LUMN | CLOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.51 | ||
| Sortino ratioReturn per unit of downside risk | +1.45 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.14 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 3.26 | 0.53 | +2.72 |
| Martin ratioReturn relative to average drawdown | 6.25 | 0.97 | +5.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LUMN | CLOV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.94 | 0.43 | +1.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.07 | -0.17 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.06 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | -0.17 | +0.35 |
Drawdowns
LUMN vs. CLOV - Drawdown Comparison
The maximum LUMN drawdown since its inception was -95.26%, roughly equal to the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for LUMN and CLOV.
Loading charts...
Drawdown Indicators
| LUMN | CLOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.26% | -97.19% | +1.93% |
Max Drawdown (1Y)Largest decline over 1 year | -47.34% | -55.50% | +8.16% |
Max Drawdown (3Y)Largest decline over 3 years | -69.66% | -64.73% | -4.93% |
Max Drawdown (5Y)Largest decline over 5 years | -92.86% | -97.19% | +4.33% |
Max Drawdown (10Y)Largest decline over 10 years | -94.44% | — | — |
Current DrawdownCurrent decline from peak | -52.10% | -81.99% | +29.89% |
Average DrawdownAverage peak-to-trough decline | -27.64% | -76.63% | +48.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.60% | 30.49% | -5.89% |
Volatility
LUMN vs. CLOV - Volatility Comparison
Lumen Technologies, Inc. (LUMN) has a higher volatility of 25.94% compared to Clover Health Investments, Corp. (CLOV) at 23.40%. This indicates that LUMN's price experiences larger fluctuations and is considered to be riskier than CLOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LUMN | CLOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.94% | 23.40% | +2.54% |
Volatility (6M)Calculated over the trailing 6-month period | 56.92% | 40.34% | +16.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.74% | 69.22% | +10.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.17% | 88.21% | -3.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 67.50% | 85.69% | -18.19% |
Dividends
LUMN vs. CLOV - Dividend Comparison
Neither LUMN nor CLOV has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LUMN Lumen Technologies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 14.37% | 7.97% | 10.26% | 7.57% | 14.26% | 12.95% | 9.08% | 8.59% |
Financials
LUMN vs. CLOV - Financials Comparison
This section allows you to compare key financial metrics between Lumen Technologies, Inc. and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LUMN vs. CLOV - Profitability Comparison
LUMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported a gross profit of 0.00 and revenue of 2.90B. Therefore, the gross margin over that period was 0.0%.
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.
LUMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported an operating income of 602.00M and revenue of 2.90B, resulting in an operating margin of 20.8%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.
LUMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lumen Technologies, Inc. reported a net income of -200.00M and revenue of 2.90B, resulting in a net margin of -6.9%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.
Frequently Asked Questions
LUMN and CLOV have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LUMN has higher volatility (25.94%) compared to CLOV (23.40%). In terms of maximum drawdown, LUMN dropped -95.26% vs CLOV's -97.19%.
LUMN currently has the higher Sharpe Ratio (1.94 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LUMN and CLOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer